MedTrace Logo

Placebo Controlled Trial of a Titanium Dioxide Semiconductor Toothbrush on Mild-to-moderate Gum Disease

NCT00167466 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2010-10-28

No results posted yet for this study

Summary

The effects on indices of gingivitis/periodontitis will differ between study arms in which the titanium dioxide semiconductor toothbrush is used, compared to an otherwise identical toothbrush with an inert resin core in place of the titanium dioxide semiconductor.

Conditions

  • Periodontal Diseases

Interventions

DEVICE

Soladey-3 toothbrush

subject to brush with experimental Soladey-3 brush for 4 week

DEVICE

Placebo Soladey-3 toothbrush

subjects will brush with placebo Soladey-3 toothbrush for 4 weeks

Sponsors & Collaborators

  • Shiken Corporation

    collaborator INDUSTRY

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Gerry Uswak · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2010-05-31
Completion
2010-05-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00167466 on ClinicalTrials.gov